1. Inicio
  2. Publicaciones
  3. Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology

Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology

Fecha de publicación: Fecha Ahead of Print:

Autores de IDIVAL

Autores ajenos al IDIVAL

  • Alonso F
  • Auñón P
  • García-Carro C
  • García P
  • Gutiérrez E
  • Mcía M
  • Quintana LF
  • Quiroga B
  • Soler MJ
  • Torregrosa I
  • Onconephrology Group of the Spanish Society of Nephrology

Abstract

The most widely used approach in the immunotherapy treatment of cancer is the administration of monoclonal antibodies directed against regulatory molecules of immune control that inhibit the activation of T cells, the so-called check point inhibitors (ICI). ICI nephrotoxicity epidemiology and pathology; its diagnosis with or without kidney biopsy; the type and duration of treatment; the possibility of rechallenging after kidney damage; and its indication in patients with cancer and renal transplantation are certainly controversial. In the absence of definitive studies, this document is intended to specify some recommenda-tions agreed by the group of onconephrology experts of the Spanish Society of Nephrology in those areas related to ICI nephrotoxicity, in order to help decision-making in daily clinical practice in onconephrology consultations.(c) 2022 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).

Copyright © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
2013-2514, 2013-2514

Nefrologia  

Tipo:
Article
Páginas:
622-635
PubMed:
38000944

Citas Recibidas en Web of Science: 6

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Acute interstitial nephritis; Acute kidney injury; Efectos inmunes renales adversos; Immune checkpoint inhibitors; Immunotherapy; Inhibidores del check-point; Inmunoterapia; Insuficiencia renal aguda; Nefritis tubulointersticial aguda; Renal immune-related adverse effect; Renal transplantation; Trasplante renal

Compartir